Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 2, 2008
Synthetic HDL as a new treatment for atherosclerosis regression: has the time come?Paola Conca, Guido FranceschiniTrends in Cardiovascular Medicine|July 27, 2010
Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humansLaura Calabresi, Guido FranceschiniFrontiers in Pharmacology|February 3, 2016
Protective Effects of HDL Against Ischemia/Reperfusion InjuryMonica Gomaraschi, Laura Calabresi, Guido FranceschiniArteriosclerosis, Thrombosis, and Vascular Biology|September 13, 2003
Endothelial protection by high-density lipoproteins: from bench to bedsideLaura Calabresi, Monica Gomaraschi, Guido FranceschiniExpert Opinion on Therapeutic Targets|July 20, 2006
High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular diseaseMonica Gomaraschi, Laura Calabresi, Guido FranceschiniCurrent Pharmaceutical Design|March 4, 2010
High-density lipoprotein quantity or quality for cardiovascular prevention?Laura Calabresi, Monica Gomaraschi, Guido FranceschiniAtherosclerosis|December 23, 2011
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular diseaseLaura Calabresi, Sara Simonelli, Monica Gomaraschi, et al.Pharmacology & Therapeutics|September 9, 2006
Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injuryLaura Calabresi, Monica Gomaraschi, Giuseppe Rossoni, et al.Current Atherosclerosis Reports|March 3, 2006
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseasesLaura Calabresi, Cesare R Sirtori, Rodolfo Paoletti, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 14, 2016
[Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy]Fabio Lucca, Alice Ossoli, Giuliano Boscutti, et al.Pageof 7